Compare Entegris Inc (ENTG) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entegris Inc vs NeoGenomics Inc. Common Stock — how do they compare? Entegris Inc trades at $147.6 (market cap $23.39B), while NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B). The key difference: Entegris Inc is far larger — about 10.8× NeoGenomics Inc. Common Stock's market cap, and Entegris Inc pays a 0.26% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Entegris Inc for 41 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| ENTG | NEO | |
|---|---|---|
Market Cap | $23.39B | $2.17B |
Volume | 2,918,074 | 1,615,943 |
Sector | Technology | Health |
52-Week High | $184.00 | $19.91 |
52-Week Low | $68.80 | $7.19 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | $26.60B | $2.47B |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Entegris Inc
Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.
Read more on ENTG →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
